Effect of simvastatin therapy on blood and tissue ATP levels and erythrocyte membrane lipid composition.

作者: S Calişkan , M Calişkan , F Kuralay , B Onvural , None

DOI:

关键词: CholesterolTriglycerideMembraneBiochemistryElectron transport chainRed blood cellChemistryInternal medicineCoenzyme AReductaseEndocrinologySimvastatin

摘要: 3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors decrease mevalonate and subsequently cholesterol synthesis competitively. Mevalonate is also the precursor of ubiquinone. Ubiquinone an important component electron transport chain. We therefore investigated effect simvastatin on rat blood tissue ATP concentrations lipid composition red cell membranes after 4 weeks therapy. Significant reductions in plasma cholesterol, triglyceride, were detected. Tissue levels not affected. Membrane phospholipids increased, while to phospholipid ratio decreased (P < 0.05). positive correlation between concentration was noted 0.05, r = 0.851). Our results show that HMG-CoA change probably functions membrane lipids concentration.

参考文章(22)
A. Lewis Farr, Oliver H. Lowry, Rose J. Randall, Nira J. Rosebrough, Protein Measurement with the Folin Phenol Reagent Journal of Biological Chemistry. ,vol. 193, pp. 265- 275 ,(1951)
S Pierno, D C Camerino, M Laico, D Tricarico, F Natuzzi, A Roselli, E Ferrannini, A De Luca, Potential risk of myopathy by HMG-CoA reductase inhibitors: a comparison of pravastatin and simvastatin effects on membrane electrical properties of rat skeletal muscle fibers. Journal of Pharmacology and Experimental Therapeutics. ,vol. 275, pp. 1490- 1496 ,(1995)
A A Manoukian, N V Bhagavan, T Hayashi, T A Nestor, C Rios, A G Scottolini, Rhabdomyolysis secondary to lovastatin therapy. Clinical Chemistry. ,vol. 36, pp. 2145- 2147 ,(1990) , 10.1093/CLINCHEM/36.12.2145
M. Zureik, D. Courbon, P. Ducimetiere, Serum cholesterol concentration and death from suicide in men: Paris prospective study I BMJ. ,vol. 313, pp. 649- 651 ,(1996) , 10.1136/BMJ.313.7058.649
Stephen MacMahon, Norman Sharpe, Greg Gamble, Hamish Hart, John Scott, John Simes, Harvey White, Effects of Lowering Average or Below-Average Cholesterol Levels on the Progression of Carotid Atherosclerosis Results of the LIPID Atherosclerosis Substudy Circulation. ,vol. 97, pp. 1784- 1790 ,(1998) , 10.1161/01.CIR.97.18.1784
L. J Herrinton, G. D Friedman, Serum cholesterol concentration and risk of brain cancer BMJ. ,vol. 310, pp. 367- 368 ,(1995) , 10.1136/BMJ.310.6976.367
Reijo Laaksonen, Kalle Jokelainen, Juha Laakso, Timo Sahi, Matti Härkönen, Matti Juhani Tikkanen, Jaakko-Juhani Himberg, The effect of Simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle* American Journal of Cardiology. ,vol. 77, pp. 851- 854 ,(1996) , 10.1016/S0002-9149(97)89180-1
G. Wannamethee, A G. Shaper, P. H Whincup, M. Walker, Low serum total cholesterol concentrations and mortality in middle aged British men. BMJ. ,vol. 311, pp. 409- 413 ,(1995) , 10.1136/BMJ.311.7002.409
Keiichi Nakahara, Masaru Kuriyama, Yoshito Sonoda, Hiroaki Yoshidome, Hiroto Nakagawa, Jiro Fujiyama, Itsuro Higuchi, Mitsuhiro Osame, Myopathy Induced by HMG–CoA Reductase Inhibitors in Rabbits: A Pathological, Electrophysiological, and Biochemical Study☆ Toxicology and Applied Pharmacology. ,vol. 152, pp. 99- 106 ,(1998) , 10.1006/TAAP.1998.8491
Andrew D. Rosenberg, Michael G. Neuwirth, Lawrence J. Kagen, Kumkum Singh, Harry D. Fischer, Ralph L. Bernstein, Intraoperative rhabdomyolysis in a patient receiving pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitor. Anesthesia & Analgesia. ,vol. 81, pp. 1089- 1091 ,(1995) , 10.1097/00000539-199511000-00034